China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 46.3% in October

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) saw a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 105,300 shares, a drop of 46.3% from the October 15th total of 196,000 shares. Approximately 3.1% of the shares of the company are sold short. Based on an average trading volume of 614,600 shares, the days-to-cover ratio is currently 0.2 days.

China SXT Pharmaceuticals Trading Down 2.1 %

Shares of SXTC stock traded down $0.01 during mid-day trading on Wednesday, reaching $0.46. The stock had a trading volume of 7,353 shares, compared to its average volume of 745,761. China SXT Pharmaceuticals has a one year low of $0.43 and a one year high of $6.39. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.60 and a quick ratio of 1.51. The firm’s 50 day simple moving average is $0.61 and its 200 day simple moving average is $0.89.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.